Download - Mohit Patel -- Disruptive Diner: Nano Possibilities

Transcript
Page 1: Mohit Patel -- Disruptive Diner: Nano Possibilities

Mohit B. Patel

The next generation of Gene Delivery

Page 2: Mohit Patel -- Disruptive Diner: Nano Possibilities

Macro Micro Nano

Millionth  (10-­‐6)    

Red  Blood  Cell  8  micrometer  

Billionth  (10-­‐9)    

DNA  2nm  wide  

Human  Being  6  feet  tall  

What is Nano?

Page 3: Mohit Patel -- Disruptive Diner: Nano Possibilities

Nanotechnology

Energy Nanomedicine Nanosensors

Broad  range  of  applica<ons  

Page 4: Mohit Patel -- Disruptive Diner: Nano Possibilities

Genetic Material

Tissue  

Cell  

Chromosome  DNA  

Body  

Gene  

Page 5: Mohit Patel -- Disruptive Diner: Nano Possibilities

Genetic Disorders

Illness  caused  by  an  abnormality  in  an  individuals  DNA/gene.  

Page 6: Mohit Patel -- Disruptive Diner: Nano Possibilities

Gene Delivery

Gene Expression

Research applications: Genetic disorders, gene therapy, protein production, functional genomics, disease diagnostics and

agriculture crop enhancement

Gene Delivery

Page 7: Mohit Patel -- Disruptive Diner: Nano Possibilities

Gene Delivery

Transfection: Laboratory procedure to delivery foreign DNA into host cells.

Page 8: Mohit Patel -- Disruptive Diner: Nano Possibilities

Microinjec5on  

Physical methods

Electropora5on   Gene  gun  

Advantage:  Can  transfer  large  DNA  molecules  Disadvantage:  Highly  cytotoxic  and  expensive  

Page 9: Mohit Patel -- Disruptive Diner: Nano Possibilities

Biological methods

Advantage:  Stable  transfec<on  Disadvantage:  High  risk  and  <me  consuming  

Page 10: Mohit Patel -- Disruptive Diner: Nano Possibilities

Nanotubes  

Chemical methods

Calcium  phosphate   Lipids  

Advantage:  Good  efficiency  Disadvantage:  Cytotoxic  and  limited  gene<c  informa<on  

Page 11: Mohit Patel -- Disruptive Diner: Nano Possibilities

Limitations of Existing Products

11  

•  Toxic to cells

•  Limited size (kilobases, kb)

•  Poor efficiency

•  Time consuming

•  Inconsistent results

•  Costly

$6000 and 30 days / year for

each scientist

“Transfection market clamors for silver bullet.”

Page 12: Mohit Patel -- Disruptive Diner: Nano Possibilities

Solution: Janus Transfection Kit™

12  

Janus Transfection Kit™ utilizes a new class of chemical reagent for DNA transformation and transfection.

New Class = non-lipid, non-viral and non-dendrimer based transfection reagent

Janus Transfection Kit™

Proprietary Platform Technology

Page 13: Mohit Patel -- Disruptive Diner: Nano Possibilities

STEP 1 STEP 2 STEP 3

Janus Transfection Reagent™

Page 14: Mohit Patel -- Disruptive Diner: Nano Possibilities

Efficiency: Janus Transfection Kit™ Bacteria Yeast

0.00%

50.00%

100.00%

Janus Transfection Reagent™

Control

Mammalian cells

0 10 20 30 40 50 60

Janus Transfection Reagent™

Control

Nu

mb

er o

f ce

lls

tran

sfom

ed

Plants

0 10 20 30 40 50 60

Janus Transfection Reagent™

Promega's Product

Col

ony

form

ing

un

its

0 100 200 300 400 500 600

Janus Transfection Reagent™

Standard Reagent

Col

ony

form

ing

un

its

Page 15: Mohit Patel -- Disruptive Diner: Nano Possibilities

Competitive Advantages

15  

Company DNA Size Toxicity Cell Versatility Price In-House <7kb High Low $ 413

Invitrogen ~9-12kb High High $ 485 Sigma Aldrich ~11kb Low Medium $ 333

Promega ~7-10kb Low Medium $ 440 Qiagen ~9-12kb Medium Medium $ 288

Genetix Fusion

>20kb None Very High $ 350

Janus Transfection Kit™ will save each researcher an estimated 65% of cost and 50% of time.

Page 16: Mohit Patel -- Disruptive Diner: Nano Possibilities

Broad range of applications

Solution: Janus Transfection Kit™

Enables use of larger DNA

High efficiency

Non-mutagenic and non-cytotoxic

Page 17: Mohit Patel -- Disruptive Diner: Nano Possibilities

Transfection Market

$13.4 Billion market DNA and RNA delivery

$346 Million

Genetix Fusion accessible market

Academia 68% ($235 M) Pre-packaged kits 75% ($259 M)

Page 18: Mohit Patel -- Disruptive Diner: Nano Possibilities

Critical Milestones

Alpha prototype

tested

Provisional patent

Genetix Fusion founded

Beta prototype

Initial funding raised

May 2012

January 2014

January 2015

Strategic distribution

partner

1% Market (~5500 units)

January 2018

4% Market (~28000 units)

Establish operations

Controlled market release

Launch first product

PCT application

Today

Page 19: Mohit Patel -- Disruptive Diner: Nano Possibilities

Now Seeking

1.  Academic researchers for beta testing

2.  Collaborative opportunities

3.  Distribution partner

4.  Seed stage investment

Page 20: Mohit Patel -- Disruptive Diner: Nano Possibilities

REDEFINING TRANSFECTION

Contact us: [email protected] www.genetixfusion.com

(314) 516-4607